Apoptosis Regulatory Proteins
"Apoptosis Regulatory Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A large group of proteins that control APOPTOSIS. This family of proteins includes many ONCOGENE PROTEINS as well as a wide variety of classes of INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS such as CASPASES.
| Descriptor ID |
D051017
|
| MeSH Number(s) |
D12.644.360.075 D12.776.476.075
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Apoptosis Regulatory Proteins".
Below are MeSH descriptors whose meaning is more specific than "Apoptosis Regulatory Proteins".
This graph shows the total number of publications written about "Apoptosis Regulatory Proteins" by people in this website by year, and whether "Apoptosis Regulatory Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 3 | 3 |
| 2001 | 0 | 3 | 3 |
| 2002 | 0 | 2 | 2 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 3 | 3 |
| 2005 | 0 | 5 | 5 |
| 2007 | 3 | 5 | 8 |
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 3 | 4 |
| 2010 | 2 | 7 | 9 |
| 2011 | 2 | 5 | 7 |
| 2012 | 3 | 3 | 6 |
| 2013 | 1 | 4 | 5 |
| 2014 | 1 | 11 | 12 |
| 2015 | 7 | 3 | 10 |
| 2016 | 0 | 2 | 2 |
| 2017 | 0 | 3 | 3 |
| 2018 | 0 | 4 | 4 |
| 2019 | 4 | 0 | 4 |
| 2020 | 4 | 2 | 6 |
| 2021 | 0 | 4 | 4 |
| 2022 | 1 | 2 | 3 |
| 2023 | 0 | 2 | 2 |
| 2024 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Apoptosis Regulatory Proteins" by people in Profiles.
-
Plasmodium berghei liver stage parasites exploit host GABARAP proteins for TFEB activation. Commun Biol. 2024 Nov 21; 7(1):1554.
-
Brain abscesses, neutropenia, and B-ALL: Multiple testing modalities required to confirm PDCD10 and ETV6 dual diagnoses. Cancer Genet. 2024 Nov; 288-289:5-9.
-
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast Cancer. Cancer Res. 2023 10 02; 83(19):3284-3304.
-
Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L. Nat Commun. 2023 04 26; 14(1):2407.
-
The CNS-penetrating taxane drug TPI 287 potentiates antiglioma activity of the AURKA inhibitor alisertib in vivo. Cancer Chemother Pharmacol. 2023 02; 91(2):191-201.
-
Mechanisms of MCL-1 Protein Stability Induced by MCL-1 Antagonists in B-Cell Malignancies. Clin Cancer Res. 2023 01 17; 29(2):446-457.
-
Caspar, an adapter for VAPB and TER94, modulates the progression of ALS8 by regulating IMD/NF?B-mediated glial inflammation in a Drosophila model of human disease. Hum Mol Genet. 2022 08 25; 31(17):2857-2875.
-
CD5L attenuates allergic airway inflammation by expanding CD11chigh alveolar macrophages and inhibiting NLRP3 inflammasome activation via HDAC2. Immunology. 2022 11; 167(3):384-397.
-
Death-associated protein kinases and intestinal epithelial homeostasis. Anat Rec (Hoboken). 2023 05; 306(5):1062-1087.
-
Maximal Activation of Apoptosis Signaling by Cotargeting Antiapoptotic Proteins in BH3 Mimetic-Resistant AML and AML Stem Cells. Mol Cancer Ther. 2022 06 01; 21(6):879-889.